Skip to content

Drug interactions

Clomipramine + Epcoritamab

Severity: Moderate

Clomipramine and Epcoritamab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Epcoritamab releases cytokines that can transiently suppress CYP enzyme activity, potentially increasing clomipramine exposure. The effect is most relevant around the first doses and during cytokine release syndrome.

What this interaction means in plain words

Clomipramine and Epcoritamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Clomipramine belongs to Central Nervous System; Epcoritamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP enzymes increases substrate concentrations.

What to do

Monitor for clomipramine toxicity, including sedation, anticholinergic effects and palpitations, during early epcoritamab treatment and any CRS. Adjust the clomipramine dose if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clomipramine and Epcoritamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Clomipramine with Epcoritamab?

MediHelp rates the interaction as moderate. Clomipramine and Epcoritamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Epcoritamab releases cytokines that can transiently suppress CYP enzyme activity, potentially increasing clomipramine exposure. The effect is most relevant around the first doses and during cytokine release syndrome.

How serious is the interaction between Clomipramine and Epcoritamab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for clomipramine toxicity, including sedation, anticholinergic effects and palpitations, during early epcoritamab treatment and any CRS. Adjust the clomipramine dose if needed.

What other medicines interact with Clomipramine?

MediHelp also lists interactions of Clomipramine with, for example, Arsenic trioxide, Dofetilide, Droperidol. The full list is on the Clomipramine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in